miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Leukemia poses a significant threat to human health.
• MicroRNAs (miRNAs) are key regulators of cellular processes including growth, proliferation, and apoptosis.
• The role of miRNAs in leukemia therapy and the specific mechanisms of miRNA143 in K562 cells require further elucidation.

Purpose of the Study:

• To investigate the effect of miRNA143 on K562 leukemia cell proliferation and apoptosis.
• To explore the underlying mechanism of miRNA143 in regulating K562 cells, focusing on BCR-ABL expression.

Main Methods:

• K562 cells were transfected with miRNA143 or scramble miRNA.
• Cell proliferation was assessed using MTT assay.
• Apoptosis was evaluated by flow cytometry and caspase-3 activity assays.
• Western blot analysis was used to determine BCR-ABL expression levels.
• BCR-ABL levels were manipulated using overexpression and siRNA to assess their impact on apoptosis.

Main Results:

• miRNA143 transfection significantly inhibited K562 cell growth and induced apoptosis.
• Transfection with miRNA143 led to a decrease in BCR-ABL expression.
• Overexpression of BCR-ABL attenuated miRNA143-induced apoptosis, whereas BCR-ABL reduction enhanced it.

Conclusions:

• miRNA143 induces apoptosis in K562 leukemia cells by downregulating BCR-ABL.
• miRNA143 demonstrates potential as a novel therapeutic target for leukemia treatment.